VYNE Therapeutics Inc.
Q1 2025 13F Holders
Symbol
VYNE
CUSIP
92941V308
Type
Equity
Class
COM
Num filings
38
Total reported value, excl. options
$11.4 M
Compare 2025 Q1 to
2024 Q4
2024 Q3
2024 Q2
2024 Q1
2023 Q4
2023 Q3
2023 Q2
2023 Q1
Manager
Report Date
Value ($000)
Shares
Option Type